<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02931227</url>
  </required_header>
  <id_info>
    <org_study_id>TempCore</org_study_id>
    <nct_id>NCT02931227</nct_id>
  </id_info>
  <brief_title>Accuracy of Zero Heat Flux Cutaneous Temperature in Intensive Care Adults</brief_title>
  <acronym>TempCore</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <brief_summary>
    <textblock>
      Temperature is one of the vital signs usually monitored in patients of ICUs. Indeed, fever
      occurs frequently in ICU especially in brain injured patients and may require targeted
      temperature management (TTM) in special case as intracranial hypertension or post cardiac
      arrest. In ICU, non invasive device to monitor temperature are not recommended and only
      invasive ones are accurate enough for TTM. Arterial pulmonary temperature is still the gold
      standard, but esophageal device is currently used in ICU patients.

      The goal of this study is to compare accuracy of a continuous noninvasive cutaneous
      temperature using zero-heat-flux (ZHF) method to esophageal temperature, arterial temperature
      and intracerebral temperature if present for clinical monitoring.

      All adults patients admitted in the neurosurgical or surgical ICU are eligible for inclusion
      into this study.

      Assessment of temperature will be continuously monitored by esophageal probe (MON-A-THERM,
      12Fr, COVIDIEN, Dublin, Ireland) (Teso), ZHF sensor (SpotOn, 3M, St Paul, MN, USA) (TZHF)
      and, in patients requiring cardiac output monitoring, by femoral arterial catheter
      (Pulsiocath PICCO, PULSION, Munich, Germany) (Tart). The correct positioning of the
      esophageal probe will be controlled by chest X-ray. The ZHF temperature sensor (TZHF) will be
      placed on the forehead as recommend by the manufacturer and connected to the SpotOn monitor.
      Intra cerebral temperature (Tbrain) will be obtained with an intracranial probe used as
      calibrator for partial pressure of O2 in brain (PbO2, LicoxÂ®Combined Oxygen and Temperature
      Probe 462 mm device necessary for monitoring severe brain injured patients. The ZHF sensor
      will be changed every 24 hours according to the manufacturer's directions for use.
      Temperatures will be recorded automatically at a 5-minutes interval via the patient's monitor
      with an electronic data acquisition system (Data Collect, Phillips) for a maximum of 5 days.

      For each patient included, data recorded will be: demographic and clinical particulars for
      each patient; information on hemodynamics, sedative, analgesic and inotropic agents, use of
      neuromuscular blockades and their indication, reason of hypo or hyperthermia (spontaneous or
      therapeutic), indication and the means used (neuromuscular blockades, external or internal
      cooling) in case of Targeted Temperature Management; complications related to the ZHF sensor
      application.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2014</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison a continuous non-invasive cutaneous temperature using zero-heat flux method</measure>
    <time_frame>5 days</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Continuous Non Invasive Cutaneous Temperature</condition>
  <condition>Zero Heat Flux Method</condition>
  <condition>Esophageal Temperature</condition>
  <condition>Arterial Temperature</condition>
  <condition>Intracerebral Temperature</condition>
  <arm_group>
    <arm_group_label>Brain-injured group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypothermia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperthermia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PICCO group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>temperature obtained by the non-invasive method of zero-heat flux</intervention_name>
    <arm_group_label>Brain-injured group</arm_group_label>
    <arm_group_label>Hypothermia group</arm_group_label>
    <arm_group_label>Hyperthermia group</arm_group_label>
    <arm_group_label>PICCO group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>esophageal temperature</intervention_name>
    <arm_group_label>Brain-injured group</arm_group_label>
    <arm_group_label>Hypothermia group</arm_group_label>
    <arm_group_label>Hyperthermia group</arm_group_label>
    <arm_group_label>PICCO group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intracerebral temperature</intervention_name>
    <arm_group_label>Brain-injured group</arm_group_label>
    <arm_group_label>Hypothermia group</arm_group_label>
    <arm_group_label>Hyperthermia group</arm_group_label>
    <arm_group_label>PICCO group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>arterial temperature</intervention_name>
    <arm_group_label>PICCO group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  minimum 18 years old

          -  patients who required core temperature monitoring

        Exclusion Criteria:

          -  front disrepair

          -  refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claire DAYHOT-FIZELIER, PU-PH</last_name>
    <phone>0549441369</phone>
    <phone_ext>+33</phone_ext>
    <email>claire.dahyot-fizelier@chu-poitiers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire DAYHOT-FIZELIER, PU-PH</last_name>
      <phone>0549441369</phone>
      <phone_ext>+33</phone_ext>
      <email>claire.dahyot-fizelier@chu-poitiers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2016</study_first_submitted>
  <study_first_submitted_qc>October 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>April 14, 2017</last_update_submitted>
  <last_update_submitted_qc>April 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

